USPTO serial 88789116
NOVARX
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- GOODSAID, IRA
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NOVARX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline M. Lesser
Jacqueline M. Lesser BAKER & HOSTETLER LLP2929 ARCH STREETCIRA CENTRE, 12TH FLOORPHILADELPHIA, PA 19104-2891Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2020 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Sep 8, 2020 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Sep 4, 2020 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 3, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 3, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 3, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 20, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 12, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 6, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 27, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 27, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 27, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 27, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 11, 2020 | NWAP | NEW APPLICATION ENTERED | — |